Bayer R&D Center To Uncover Chinese Insights
Executive Summary
A new dedicated R&D facility for Bayer Consumer Health in China will enable the firm to “quickly take the pulse of the market” and transform demand into innovative products.
You may also be interested in...
Bayer Hopes Consumer Health Woes Are In Rear View Mirror As Business Returns To Growth
Bayer is starting to see green shoots of recovery after a prolonged period of declining sales and earnings at its Consumer Health business. Turnover improved by 2% in the second quarter, driven by gains in Europe and Latin America.
Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018
Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.
Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth
Bayer's Consumer Health chief Heiko Schipper is hoping a focus on innovation and a leaner portfolio will help return the business to mid-single-digit growth by 2022. The German firm has identified its North American business as the 'key area to fix'.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: